Towards Healthcare
Cell and Gene Overexpression Service Market to Reach USD 1,192.24 Mn by 2034

Cell and Gene Overexpression Service Market Research Update

Market insights predict, the cell and gene overexpression service industry is expected to grow from USD 771.40 million in 2024 to USD 1,192.24 million by 2034, driven by a CAGR of 4.45%. The cell and gene overexpression service market is expanding due to growing demand for biologics as well as growth in plasmid-based transfection use. North America led the market due to the presence of robust industries.

Content

  • Insight Code: 6090
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The cell and gene overexpression market holds a valuation of USD 805.73 million as of 2025, and will expand to USD 1,192.24 million by 2034, achieving a CAGR of 4.45% between 2024 and 2034.

North America is currently leading the cell and gene overexpression service market due to the presence of robust industries.

Some key players include GenScript Biotech, Charles River Laboratories, Lonza Group, and WuXi AppTec.

Key trends include increasing demand for targeted therapies and collaborations.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions